journal article·2026-07Open access

Streptavidin functionalized hyaluronic acid hydrogels for controlled and customizable drug delivery

Emily E. Sharp, Lorielle Laforest, Yuqi Zhang, Karen L. Xu, Zhiliang Cheng, Jason A. Burdick, Sarah E. Gullbrand, Robert L. Mauck

Abstract

Hyaluronic acid (HA)-based hydrogels have emerged as promising materials for tissue repair given their ability to rapidly gel in situ to precisely fill tissue defects, their mechanical tunability and customizable degradation kinetics, and their capacity to deliver therapeutic agents to the site of injury. HA hydrogels can also be used to encapsulate therapeutics for local delivery; however, release through diffusion may be too rapid to achieve a therapeutic window for many applications. To overcome this limitation, we functionalized norbornene-modified HA (NorHA) hydrogels with streptavidin using thiol-ene click chemistry, enabling efficient tethering of biotin-modified agents (i.e., fluorophores, liposomes) to the hydrogel. We first confirmed that streptavidin functionalization increased the retention of encapsulated agents both in vitro and in vivo and did not impact hydrogel properties (including rapid gelation or mechanical tunability). Next, we incorporated matrix metalloproteinase (MMP) degradable crosslinks to further tune hydrogel degradation, permitting increased cellular invasion in vivo without disrupting retention and delivery of biotin-modified fluorophores. Lastly, streptavidin functionalized hydrogels were used to encapsulate and control the release of liposomes, with customizable release of model therapeutics within the liposome core and membrane. Overall, these findings support a promising material to control the release of therapeutics that could be useful in a variety of biomedical applications. STATEMENT OF SIGNIFICANCE: Soft tissue injuries are ubiquitous and a significant cause of disability in society. Functionalized hydrogels enable controlled delivery of therapeutics to promote tissue repair. In this study we demonstrated that streptavidin functionalization of hyaluronic acid-based hydrogels successfully tethers biotin-modified agents, prolonging their localized delivery. Functionalization did not impact hydrogel gelation, mechanical tunability, or the ability to tailor hydrogel degradation. Further, the tethering of biotin-modified liposome nanocarriers enabled staged delivery of multiple agents. Altogether, our results highlight streptavidin functionalized hydrogels as a promising platform to promote endogenous healing and tissue regeneration through controlled spatiotemporal delivery.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Hydrogels: synthesis, properties, applications · Polymer Surface Interaction Studies · Cellular Mechanics and Interactions

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (79)

Show source-provided references
1. Global Burden of Disease Collaborative Network, Global Burden of Disease Study 2019 (GBD 2019) Healthcare Access and Quality Index 1990-2019, (2022). https://doi.org/10.6069/97EM-P280.
2. Musculoskeletal health: an ecological study assessing disease burden and research funding
3. Global, regional, and national burden of other musculoskeletal disorders, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 202110.1016/S2665-9913(23)00232-1 ↗
4. Current Trends in orthobiologics: an 11-year review of the orthopaedic literature10.1177/03635465211037343 ↗
5. Cell-based therapies for degenerative musculoskeletal diseases10.1002/advs.202207050 ↗
6. Hydrogels for tissue engineering: scaffold design variables and applications10.1016/S0142-9612(03)00340-5 ↗
7. Hydrogels for tissue engineering10.1021/cr000108x ↗
8. Designing hydrogels for controlled drug delivery10.1038/natrevmats.2016.71 ↗
9. Advances in engineering hydrogels10.1126/science.aaf3627 ↗
10. Exploring the formulation and approaches of injectable hydrogels utilizing hyaluronic acid in biomedical uses10.1155/2024/3869387 ↗
11. Therapeutic hydrogels: properties and biomedical applications10.1021/acs.chemrev.5c00182 ↗
12. Hyaluronic acid: molecular mechanisms and therapeutic trajectory10.3389/fvets.2019.00192 ↗
13. Hyaluronic acid as a versatile building block for the development of biofunctional hydrogels: In vitro models and preclinical innovations
14. Hyaluronic acid hydrogels for biomedical applications10.1002/adma.201003963 ↗
15. Combined nucleus pulposus augmentation and annulus fibrosus repair prevents acute intervertebral disc degeneration after discectomy10.1126/scitranslmed.aay2380 ↗
16. Supramolecular injectable hyaluronate hydrogels for cartilage tissue regeneration10.1021/acsabm.0c00537 ↗
17. Hyaluronic acid-based interpenetrating network hydrogel as a cell carrier for nucleus pulposus repair10.1016/j.carbpol.2021.118828 ↗
18. Optimization of hyaluronic acid-tyramine/silk-fibroin composite hydrogels for cartilage tissue engineering and delivery of anti-inflammatory and anabolic drugs10.1016/j.msec.2020.111701 ↗
19. In situ cross-linkable hyaluronic acid hydrogels using copper free click chemistry for cartilage tissue engineering10.1039/C7PY01654A ↗
20. Harnessing the potential of hyaluronic acid methacrylate (HAMA) hydrogel for clinical applications in orthopaedic diseases
21. Cartilage-penetrating hyaluronic acid hydrogel preserves tissue content and reduces chondrocyte catabolism10.1002/term.3352 ↗
22. Metabolic labeling of secreted matrix to investigate cell–material interactions in tissue engineering and mechanobiology10.1038/s41596-021-00652-9 ↗
23. pH-responsive modified HAMA microspheres regulate the inflammatory microenvironment of intervertebral discs10.1021/acsami.4c14475 ↗
24. Influence of gel properties on neocartilage formation by auricular chondrocytes photoencapsulated in hyaluronic acid networks10.1002/jbm.a.30660 ↗
25. A biofabrication method to align cells within bioprinted photocrosslinkable and cell-degradable hydrogel constructs via embedded fibers10.1088/1758-5090/ac25cc ↗
26. Precision repair of zone-specific meniscal injuries using a tunable extracellular matrix-based hydrogel system
27. Injectable radiopaque hyaluronic acid granular hydrogels for intervertebral disc repair10.1002/adhm.202303326 ↗
28. Photoreactive hydrogel stiffness influences volumetric muscle loss repair10.1089/ten.tea.2021.0137 ↗
29. Fabrication of MSC-laden composites of hyaluronic acid hydrogels reinforced with MEW scaffolds for cartilage repair10.1088/1758-5090/ac3acb ↗
30. Synthesis and orthogonal photopatterning of hyaluronic acid hydrogels with thiol-norbornene chemistry10.1016/j.biomaterials.2013.08.089 ↗
31. Programmable and contractile materials through cell encapsulation in fibrous hydrogel assemblies10.1126/sciadv.abi8157 ↗
32. Fragmenting bulk hydrogels and processing into granular hydrogels for biomedical applications10.3791/63867-v ↗
33. Synthesis, characterization, and digital light processing of a hydrolytically degradable hyaluronic acid hydrogel10.1021/acs.biomac.2c01218 ↗
34. The effects of varying poly(ethylene glycol) hydrogel crosslinking density and the crosslinking mechanism on protein accumulation in three-dimensional hydrogels10.1016/j.actbio.2014.05.023 ↗
35. Nelson · 2013
36. Thiol–norbornene photoclick hydrogels for tissue engineering applications10.1002/app.41563 ↗
37. Thiol–ene click hydrogels for therapeutic delivery10.1021/acsbiomaterials.5b00420 ↗
38. Genetically encoded norbornene directs site-specific cellular protein labelling via a rapid bioorthogonal reaction10.1038/nchem.1250 ↗
39. Multifunctional biohybrid hydrogels for cell culture and controlled drug release10.1039/c3cc43711f ↗
40. The modulation of MSC integrin expression by RGD presentation10.1016/j.biomaterials.2013.01.091 ↗
41. Functionalization of hyaluronic acid hydrogels with ECM-derived peptides to control myoblast behavior10.1016/j.actbio.2018.11.030 ↗
42. The principles and applications of avidin-based nanoparticles in drug delivery and diagnosis10.1016/j.jconrel.2016.11.016 ↗
43. Functional consequences of glucose and oxygen deprivation on engineered mesenchymal stem cell-based cartilage constructs10.1016/j.joca.2014.09.012 ↗
44. Enhancing the potency of growth factor-mimicking peptides via cross-presentation with Integrin Ligands10.1002/jbm.a.37944 ↗
45. Latent TGF-β hydrogels for cartilage tissue engineering10.1002/adhm.201200038 ↗
46. Click functionalized, tissue-specific hydrogels for osteochondral tissue engineering10.1002/jbm.a.36848 ↗
47. Growth-factor free multicomponent nanocomposite hydrogels that stimulate bone formation10.1002/adfm.201906205 ↗
48. Functionalized hydrogels for articular cartilage tissue engineering10.1016/j.eng.2022.03.008 ↗
49. Covalently tethered transforming growth factor beta in PEG hydrogels promotes chondrogenic differentiation of encapsulated human mesenchymal stem cells10.1007/s13346-012-0090-2 ↗
50. Semisynthetic hyaluronic acid-based hydrogel promotes recovery of the injured tibialis anterior skeletal muscle form and function10.1021/acsbiomaterials.0c01751 ↗
51. Injectable laminin-biofunctionalized gellan gum hydrogels loaded with myoblasts for skeletal muscle regeneration10.1016/j.actbio.2022.03.008 ↗
52. Integrated bioactive scaffold with aptamer-targeted stem cell recruitment and growth factor-induced pro-differentiation effects for anisotropic meniscal regeneration10.1002/btm2.10302 ↗
53. High-performance multi-dynamic bond cross-linked hydrogel with spatiotemporal siRNA delivery for gene–Cell combination therapy of intervertebral disc degeneration
54. Vanillin-based functionalization strategy to construct multifunctional microspheres for treating inflammation and regenerating intervertebral disc
55. Temporally controlled photouncaged epidermal growth factor influences cell fate in hydrogels10.1021/acsbiomaterials.1c00941 ↗
56. A hyaluronidase-responsive nanoparticle-based drug delivery system for targeting colon cancer cells10.1158/0008-5472.CAN-16-1681 ↗
57. Hydrogels in the immune context: In vivo applications for modulating immune responses in cancer therapy10.3390/gels11110889 ↗
58. Translating musculoskeletal bioengineering into tissue regeneration therapies10.1126/scitranslmed.abn9074 ↗
59. Recent evidence for orthobiologics combined with hydrogels for joint tissue regeneration: focus on osteoarthritis10.3390/gels11070551 ↗
60. Enhanced proteolytic degradation of molecularly engineered PEG hydrogels in response to MMP-1 and MMP-210.1016/j.biomaterials.2010.06.061 ↗
61. Injectable and bioresponsive hydrogels for on-demand matrix metalloproteinase inhibition10.1038/nmat3922 ↗
62. Maleimide cross-linked bioactive PEG hydrogel exhibits improved reaction kinetics and cross-linking for cell encapsulation and In situ delivery10.1002/adma.201103574 ↗
63. Degradation-mediated cellular traction directs stem cell fate in covalently crosslinked three-dimensional hydrogels10.1038/nmat3586 ↗
64. Synergistic effects of SDF-1α and BMP-2 delivery from proteolytically degradable hyaluronic acid hydrogels for bone repair10.1002/mabi.201500178 ↗
65. Transforming medicine: cutting-edge applications of nanoscale materials in drug delivery10.1021/acsnano.4c09566 ↗
66. Thiol-click chemistry: a multifaceted toolbox for small molecule and polymer synthesis10.1039/b901979k ↗
67. The power of thiol-ene chemistry10.1002/pola.23824 ↗
68. A tunable tumor microenvironment through recombinant bacterial collagen-hyaluronic acid hydrogels10.1021/acsabm.2c00186 ↗
69. Specific VEGF sequestering and release using peptide-functionalized hydrogel microspheres10.1016/j.biomaterials.2012.01.032 ↗
70. Development and in vitro assessment of enzymatically-responsive poly(ethylene glycol) hydrogels for the delivery of therapeutic peptides10.1016/j.biomaterials.2014.08.019 ↗
71. Temporally tunable, enzymatically responsive delivery of proangiogenic peptides from poly(ethylene glycol) hydrogels10.1002/adhm.201500304 ↗
72. Micropatterning of bioactive heparin-based hydrogels10.1039/C0SM00771D ↗
73. Cell-mediated delivery of glucocorticoids from thiol-ene hydrogels10.1016/j.jconrel.2012.08.002 ↗
74. Transdermal photopolymerization for minimally invasive implantation10.1073/pnas.96.6.3104 ↗
75. Thiol-cleavable biotin for chemical and enzymatic biotinylation and its application to mitochondrial TurboID proteomics10.1021/jasms.1c00079 ↗
76. Role of biotin-binding affinity in streptavidin-based pretargeted radioimmunotherapy of lymphoma10.1021/bc034049g ↗
77. Polyethylene glycol modification of a galactosylated streptavidin clearing agent: effects on immunogenicity and clearance of a biotinylated anti-tumour antibody10.1038/bjc.1996.99 ↗
78. Mirror-image D-core streptavidin exhibits reduced immunogenicity and comparable biodistribution to natural core streptavidin in mice10.1248/cpb.c25-00534 ↗
79. Mutations for decreasing the immunogenicity and maintaining the function of core streptavidin10.1002/pro.2203 ↗